SE426589B - Optiskt aktiv prostaglandinanalog till anvendning som verkframkallande medel eller medel for utforande av ett embryo eller fetus hos gravida kvinnor eller drektiga hondeggdjur - Google Patents

Optiskt aktiv prostaglandinanalog till anvendning som verkframkallande medel eller medel for utforande av ett embryo eller fetus hos gravida kvinnor eller drektiga hondeggdjur

Info

Publication number
SE426589B
SE426589B SE7511019A SE7511019A SE426589B SE 426589 B SE426589 B SE 426589B SE 7511019 A SE7511019 A SE 7511019A SE 7511019 A SE7511019 A SE 7511019A SE 426589 B SE426589 B SE 426589B
Authority
SE
Sweden
Prior art keywords
pregnant
fatus
embryo
employee
money
Prior art date
Application number
SE7511019A
Other languages
English (en)
Swedish (sv)
Other versions
SE7511019L (sv
Inventor
G A Youngdale
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE7511019L publication Critical patent/SE7511019L/xx
Publication of SE426589B publication Critical patent/SE426589B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7511019A 1974-10-02 1975-10-01 Optiskt aktiv prostaglandinanalog till anvendning som verkframkallande medel eller medel for utforande av ett embryo eller fetus hos gravida kvinnor eller drektiga hondeggdjur SE426589B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/511,220 US3974195A (en) 1974-10-02 1974-10-02 2A,2B-Dihomo-15-alkyl-PGF2.sub.α analogs

Publications (2)

Publication Number Publication Date
SE7511019L SE7511019L (sv) 1976-04-05
SE426589B true SE426589B (sv) 1983-01-31

Family

ID=24033962

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7511019A SE426589B (sv) 1974-10-02 1975-10-01 Optiskt aktiv prostaglandinanalog till anvendning som verkframkallande medel eller medel for utforande av ett embryo eller fetus hos gravida kvinnor eller drektiga hondeggdjur

Country Status (10)

Country Link
US (4) US3974195A (fr)
JP (1) JPS5852992B2 (fr)
BE (1) BE834133A (fr)
CA (1) CA1060889A (fr)
DE (1) DE2542686A1 (fr)
FR (1) FR2286645A1 (fr)
GB (1) GB1482496A (fr)
NL (1) NL7511429A (fr)
SE (1) SE426589B (fr)
ZA (1) ZA755620B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051236A (en) * 1973-02-15 1977-09-27 E. R. Squibb & Sons, Inc. Inhibition of blood platelet aggregation
TW224942B (fr) * 1990-04-04 1994-06-11 Adka Ueno Kk
JPH07113012B2 (ja) * 1991-01-29 1995-12-06 株式会社アールテック・ウエノ 新規15−ケト−プロスタグランジン類
EP0857718B1 (fr) 1996-06-10 2002-08-14 Sucampo AG Antagoniste de l'endotheline
DE19812353A1 (de) * 1998-03-20 1999-10-14 Struck Innovative Systeme Gmbh Verfahren und Vorrichtung zur Erkennung von periodischen Walzmarken

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514383A (en) * 1967-06-26 1970-05-26 Upjohn Co Process for preparing prostaglandins and analogs thereof
JPS503362B1 (fr) * 1970-06-10 1975-02-04
US3904679A (en) * 1972-05-23 1975-09-09 Upjohn Co 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs

Also Published As

Publication number Publication date
US4057564A (en) 1977-11-08
US3974195A (en) 1976-08-10
CA1060889A (fr) 1979-08-21
ZA755620B (en) 1976-08-25
US4081471A (en) 1978-03-28
GB1482496A (en) 1977-08-10
FR2286645A1 (fr) 1976-04-30
DE2542686A1 (de) 1976-04-15
JPS5159842A (fr) 1976-05-25
JPS5852992B2 (ja) 1983-11-26
FR2286645B1 (fr) 1979-09-14
NL7511429A (nl) 1976-04-06
US4082783A (en) 1978-04-04
SE7511019L (sv) 1976-04-05
BE834133A (fr) 1976-04-02
AU8454775A (en) 1977-03-10

Similar Documents

Publication Publication Date Title
SE425311B (sv) 5-oxaprostaglandiner till anvendning for utstotning av ett embryo eller ett fetus under en normal human graviditet
CH325288A (de) Impfbesteck
CH391931A (de) Verfahren zur Herstellung eines Farbstoffentwicklers
CH331394A (it) Cilindro maestro per un impianto di frenatura idraulica di un veicolo
SE426589B (sv) Optiskt aktiv prostaglandinanalog till anvendning som verkframkallande medel eller medel for utforande av ett embryo eller fetus hos gravida kvinnor eller drektiga hondeggdjur
CH338927A (de) Verfahren zur Herstellung eines Kallikrein-Inaktivators
CH334138A (de) Verfahren zur Herstellung von bisher unbekannten Phenothiazin-Derivaten
NO146280C (no) Bis-tetrahydropyranyleter for anvendelse som mellomprodukt for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien
SE434153B (sv) 4,5-didehydroprostaglandiner till anvendning som verkframkallande medel eller medel for utstotning av ett embryo eller fetus hos gravida eller drektiga hondeggdjur
CH335677A (de) Verfahren zur Herstellung von Diimidazolderivaten
DK126931B (da) Fremgangsmåde til fremstilling af optisk aktiv lysin eller et almindeligt syreadditionssalt deraf.
FR1095221A (fr) Poutre de coffrage
FR1122576A (fr) Compositions colorantes aqueuses
FR1100976A (fr) Vibreur électro-hydraulique
CH322556A (fr) Eclosoir
FR1116308A (fr) Essuie-glace
SE426696B (sv) Optiskt aktiv 16,16-dimetyl-2a,2b-dihomoprostaglandin till anvendning som verkmedel eller medel for utstotning av ett embryo eller fetus ut gravida eller drektiga hondeggdjur
CH336067A (de) Verfahren zur Herstellung von Norpethidinderivaten
ES40600Y (es) Azulejo-baldosilla para paredes
FR1114675A (fr) Forme à fumier
GR16041B (el) Μεθοδος δια την παρασκευην ενος νεου εστερος.
GR14969B (el) Νεος τροπος κατασκευης υποδηματων δια χρησιμοποιησεως ειδικων καρφιων.
ES44439Y (es) Pisos de cerámica para la construcción
ES42499Y (es) Nueva máquina para la fijación de bandeletas de goma al calzado
ES41499Y (es) Clavo